It has been found that miR-124 can inhibit the proliferation of gastric cancer cells by directly targeting the EZH2 gene, and miR-124 has an additive effect with conventional chemotherapy 5-fluorouracil (5-FU), which has the potential to become a new treatment method for gastric cancer [121]. This evidence concerns the gene EZH2 and gastric cancer.